Consequently, plasma C4 level is recommended as an innovative clinical predictor for HD patients, together with other risk-related variables, such as age, blood pressure, albumin, blood platelet count, etc. Further studies are required to thoroughly elucidate the significance and mechanisms of plasma C4 in HD patients. The gene discussed is C4A; the disease is Huntington disease.